Roger Adsett
Director de Operaciones en INSMED INCORPORATED .
Fortuna: 4 M $ al 30/04/2024
Cargos activos de Roger Adsett
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INSMED INCORPORATED | Director de Operaciones | 14/11/2019 | - |
Corporate Officer/Principal | 27/09/2016 | 14/11/2019 |
Historial de carrera de Roger Adsett
Antiguos cargos conocidos de Roger Adsett.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LANDOS BIOPHARMA, INC. | Director/Miembro de la Junta | 08/03/2022 | 23/05/2024 |
Independent Dir/Board Member | 08/03/2022 | 23/05/2024 | |
SHIRE | Corporate Officer/Principal | 01/10/2005 | 01/09/2016 |
ASTRAZENECA PLC | Ventas & Marketing | 01/11/1994 | 01/10/2005 |
Nexium, Inc. | Ventas & Marketing | - | - |
AstraZeneca R & D Lund | Ventas & Marketing | - | - |
Formación de Roger Adsett.
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Bucknell University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Irlanda | 2 |
Suecia | 2 |
Operativa
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
INSMED INCORPORATED | Health Technology |
ASTRAZENECA PLC | Health Technology |
LANDOS BIOPHARMA, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
AstraZeneca R & D Lund | |
Nexium, Inc. | Finance |
- Bolsa de valores
- Insiders
- Roger Adsett
- Experiencia